CANbridge Pharmaceuticals Inc.
HKEX:1228.HK
0.195 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 137.491 | 451.157 | 745.815 | 360.804 | 13.873 |
| Short Term Investments
| 12.59 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 137.491 | 451.157 | 745.815 | 360.804 | 13.873 |
| Net Receivables
| 31.228 | 19.054 | 9.141 | 7.04 | 0.593 |
| Inventory
| 8.783 | 9.824 | 13.448 | 0.553 | 1.447 |
| Other Current Assets
| 32.362 | 13.175 | 43.307 | 22.648 | 21.992 |
| Total Current Assets
| 209.864 | 505.16 | 811.711 | 391.045 | 37.905 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 109.007 | 125.595 | 29.542 | 15.57 | 8.862 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 76.491 | 68.133 | 51.269 | 179.743 | 41.783 |
| Goodwill and Intangible Assets
| 76.491 | 68.133 | 51.269 | 179.743 | 41.783 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 3.157 | -80.811 | -195.313 | -50.645 |
| Total Non-Current Assets
| 185.498 | 196.885 | 80.811 | 195.313 | 50.645 |
| Total Assets
| 395.362 | 702.045 | 892.522 | 586.358 | 88.55 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 198.054 | 107.54 | 43.607 | 46.713 | 6.576 |
| Short Term Debt
| 34.724 | 39.895 | 38.75 | 27.833 | 12.539 |
| Tax Payables
| 2.477 | 1.382 | 1.477 | 0.995 | 0.71 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 92.69 | 129.288 | 101.946 | 32.562 | 23.924 |
| Total Current Liabilities
| 327.945 | 278.105 | 185.78 | 108.103 | 43.749 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 107.205 | 115.385 | 13.351 | 19.062 | 1,032.271 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 2,205.049 | 3.176 |
| Total Non-Current Liabilities
| 107.205 | 115.385 | 13.351 | 2,224.111 | 1,035.447 |
| Total Liabilities
| 435.15 | 393.49 | 199.131 | 2,332.214 | 1,079.196 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.028 | 0.028 | 0.028 | 0.005 | 0.005 |
| Retained Earnings
| -3,789.442 | -3,410.605 | -2,927.13 | -1,850.124 | -1,004.081 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 247.876 | 149.886 | 77.899 | 3.849 |
| Other Total Stockholders Equity
| 3,749.626 | 3,471.256 | 3,470.607 | 26.364 | 9.581 |
| Total Shareholders Equity
| -39.788 | 308.555 | 693.391 | -1,745.856 | -990.646 |
| Total Equity
| -39.788 | 308.555 | 693.391 | -1,745.856 | -990.646 |
| Total Liabilities & Shareholders Equity
| 395.362 | 702.045 | 892.522 | 586.358 | 88.55 |